Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:1992132rdf:typepubmed:Citationlld:pubmed
pubmed-article:1992132lifeskim:mentionsumls-concept:C0087111lld:lifeskim
pubmed-article:1992132lifeskim:mentionsumls-concept:C0025202lld:lifeskim
pubmed-article:1992132lifeskim:mentionsumls-concept:C0039957lld:lifeskim
pubmed-article:1992132lifeskim:mentionsumls-concept:C0243072lld:lifeskim
pubmed-article:1992132pubmed:issue1lld:pubmed
pubmed-article:1992132pubmed:dateCreated1991-3-12lld:pubmed
pubmed-article:1992132pubmed:abstractTextBoron-containing derivatives of 2-thiouracil and 2,4-dithiouracil and the corresponding 6-propyl compounds, containing a dihydroxyboryl group in the 5-position, have been prepared. These compounds accumulate in B16 melanoma in mice in concentrations up to 30 micrograms of boron per gram tissue. The uptake persists. The toxicity of both 2-thiouracil derivatives is low. These compounds are therefore good candidates for boron neutron-capture therapy of malignant melanoma.lld:pubmed
pubmed-article:1992132pubmed:languageenglld:pubmed
pubmed-article:1992132pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:1992132pubmed:citationSubsetIMlld:pubmed
pubmed-article:1992132pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:1992132pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:1992132pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:1992132pubmed:statusMEDLINElld:pubmed
pubmed-article:1992132pubmed:monthJanlld:pubmed
pubmed-article:1992132pubmed:issn0022-2623lld:pubmed
pubmed-article:1992132pubmed:authorpubmed-author:GabelDDlld:pubmed
pubmed-article:1992132pubmed:authorpubmed-author:TjarksWWlld:pubmed
pubmed-article:1992132pubmed:issnTypePrintlld:pubmed
pubmed-article:1992132pubmed:volume34lld:pubmed
pubmed-article:1992132pubmed:ownerNLMlld:pubmed
pubmed-article:1992132pubmed:authorsCompleteYlld:pubmed
pubmed-article:1992132pubmed:pagination315-9lld:pubmed
pubmed-article:1992132pubmed:dateRevised2006-11-15lld:pubmed
pubmed-article:1992132pubmed:meshHeadingpubmed-meshheading:1992132-...lld:pubmed
pubmed-article:1992132pubmed:meshHeadingpubmed-meshheading:1992132-...lld:pubmed
pubmed-article:1992132pubmed:meshHeadingpubmed-meshheading:1992132-...lld:pubmed
pubmed-article:1992132pubmed:meshHeadingpubmed-meshheading:1992132-...lld:pubmed
pubmed-article:1992132pubmed:meshHeadingpubmed-meshheading:1992132-...lld:pubmed
pubmed-article:1992132pubmed:meshHeadingpubmed-meshheading:1992132-...lld:pubmed
pubmed-article:1992132pubmed:meshHeadingpubmed-meshheading:1992132-...lld:pubmed
pubmed-article:1992132pubmed:meshHeadingpubmed-meshheading:1992132-...lld:pubmed
pubmed-article:1992132pubmed:meshHeadingpubmed-meshheading:1992132-...lld:pubmed
pubmed-article:1992132pubmed:meshHeadingpubmed-meshheading:1992132-...lld:pubmed
pubmed-article:1992132pubmed:year1991lld:pubmed
pubmed-article:1992132pubmed:articleTitleBoron-containing thiouracil derivatives for neutron-capture therapy of melanoma.lld:pubmed
pubmed-article:1992132pubmed:affiliationDepartment of Chemistry, University of Bremen, Federal Republic of Germany.lld:pubmed
pubmed-article:1992132pubmed:publicationTypeJournal Articlelld:pubmed
pubmed-article:1992132pubmed:publicationTypeComparative Studylld:pubmed
pubmed-article:1992132pubmed:publicationTypeResearch Support, Non-U.S. Gov'tlld:pubmed
http://linkedlifedata.com/r...http://linkedlifedata.com/r...pubmed-article:1992132lld:chembl
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:1992132lld:pubmed